Ladrière L, Malaisse-Lagae F, Fuhlendorff J, Malaisse W J
Laboratory of Experimental Medicine, Brussels Free University, Belgium.
Res Commun Mol Pathol Pharmacol. 1997 Jul;97(1):53-9.
The hypoglycemic agents, glibenclamide and repaglinide, when administered intragastrically to overnight fasted hereditarily diabetic animals, were found to oppose the rise in the plasma insulin/glucose ratio otherwise evoked by refeeding of the GK rats. Such was not the case after oral administration of glimepiride, despite the fact that this sulfonylurea minimized the rise in glycemia associated with refeeding. The altered restoration of a high insulin/glucose ratio in GK rats that received glibenclamide or repaglinide before refeeding suggests that these long-acting hypoglycemic agents may delay the refeeding-induced relief of the B-cell from the fasting-associated refractoriness to glucose.
给空腹过夜的遗传性糖尿病动物经胃给予降糖药格列本脲和瑞格列奈后,发现它们能对抗再喂食GK大鼠后血浆胰岛素/葡萄糖比值的升高,而这一比值在再喂食时通常会升高。尽管格列美脲这种磺脲类药物能最大程度地降低与再喂食相关的血糖升高,但口服该药物后情况并非如此。在再喂食前接受格列本脲或瑞格列奈的GK大鼠中,胰岛素/葡萄糖比值的恢复发生改变,这表明这些长效降糖药可能会延迟再喂食诱导的胰岛B细胞从与禁食相关的葡萄糖不应性中恢复过来。